Patents by Inventor Joseph David Rosenblatt

Joseph David Rosenblatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody-endostatin fusion protein and its variants
    Patent number: 9611313
    Abstract: Methods of inhibiting the growth of tumors comprising administering chimeric fusion molecules comprising endostatin mutants and all or a portion of anti-Her2 or anti-EGFR antibodies.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: April 4, 2017
    Assignee: UNIVERSITY OF MIAMI
    Inventors: Seung-Uon Shin, Joseph David Rosenblatt, Sherie L. Morrison
  • ANTIBODY- ENDOSTATIN FUSION PROTEIN AND ITS VARIANTS
    Publication number: 20140220016
    Abstract: Methods of inhibiting the growth of tumors comprising administering chimeric fusion molecules comprising endostatin mutants and all or a portion of anti-Her2 or anti-EGFR antibodies.
    Type: Application
    Filed: April 16, 2014
    Publication date: August 7, 2014
    Applicant: University of Miami
    Inventors: Seung-Uon Shin, Joseph David Rosenblatt, Sherie L. Morrison
  • ANTIBODY- ENDOSTATIN FUSION PROTEIN AND ITS VARIANTS
    Publication number: 20110038865
    Abstract: Chimeric molecules comprising endostatin and all or a portion of a tumor antigen specific binding molecule for use in treating tumors. The chimeric molecule, includes endostatin, endostatin mutants and variants and an antibody or aptamer specific for a desired tumor antigen. Methods of treating cancer comprise administering the chimeric fusion molecules.
    Type: Application
    Filed: June 26, 2008
    Publication date: February 17, 2011
    Applicant: University of Miami
    Inventors: Seung-Uon Shin, Joseph David Rosenblatt, Sherie L. Morrison